201 related articles for article (PubMed ID: 26464264)
1. CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.
Ianes C; Xu P; Werz N; Meng Z; Henne-Bruns D; Bischof J; Knippschild U
Amino Acids; 2016 Feb; 48(2):579-92. PubMed ID: 26464264
[TBL] [Abstract][Full Text] [Related]
2. CK1δ kinase activity is modulated by protein kinase C α (PKCα)-mediated site-specific phosphorylation.
Meng Z; Bischof J; Ianes C; Henne-Bruns D; Xu P; Knippschild U
Amino Acids; 2016 May; 48(5):1185-97. PubMed ID: 26803658
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo.
Giamas G; Hirner H; Shoshiashvili L; Grothey A; Gessert S; Kühl M; Henne-Bruns D; Vorgias CE; Knippschild U
Biochem J; 2007 Sep; 406(3):389-98. PubMed ID: 17594292
[TBL] [Abstract][Full Text] [Related]
4. Site-specific phosphorylation of casein kinase 1 δ (CK1δ) regulates its activity towards the circadian regulator PER2.
Eng GWL; Edison ; Virshup DM
PLoS One; 2017; 12(5):e0177834. PubMed ID: 28545154
[TBL] [Abstract][Full Text] [Related]
5. Kinase activity of casein kinase 1 delta (CK1δ) is modulated by protein kinase C α (PKCα) by site-specific phosphorylation within the kinase domain of CK1δ.
Meng Z; Böhm T; Xu P; Henne-Bruns D; Peifer C; Witt L; Knippschild U; Bischof J
Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):710-721. PubMed ID: 31096047
[TBL] [Abstract][Full Text] [Related]
6. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
[TBL] [Abstract][Full Text] [Related]
7. Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2.
Danilov AV; Hu S; Orr B; Godek K; Mustachio LM; Sekula D; Liu X; Kawakami M; Johnson FM; Compton DA; Freemantle SJ; Dmitrovsky E
Mol Cancer Ther; 2016 Nov; 15(11):2758-2766. PubMed ID: 27550941
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics.
Choudhary GS; Tat TT; Misra S; Hill BT; Smith MR; Almasan A; Mazumder S
Oncotarget; 2015 Jul; 6(19):16912-25. PubMed ID: 26219338
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation.
Sharma P; Sharma M; Amin ND; Albers RW; Pant HC
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11156-60. PubMed ID: 10500146
[TBL] [Abstract][Full Text] [Related]
10. CK1δ kinase activity is modulated by Chk1-mediated phosphorylation.
Bischof J; Randoll SJ; Süßner N; Henne-Bruns D; Pinna LA; Knippschild U
PLoS One; 2013; 8(7):e68803. PubMed ID: 23861943
[TBL] [Abstract][Full Text] [Related]
11. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
Schmid G; Strosznajder JB; Wesierska-Gadek J
Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer.
Rajput S; Khera N; Guo Z; Hoog J; Li S; Ma CX
Oncotarget; 2016 Aug; 7(35):56864-56875. PubMed ID: 27486754
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
[TBL] [Abstract][Full Text] [Related]
14. Development of CDK2 and CDK5 Dual Degrader TMX-2172.
Teng M; Jiang J; He Z; Kwiatkowski NP; Donovan KA; Mills CE; Victor C; Hatcher JM; Fischer ES; Sorger PK; Zhang T; Gray NS
Angew Chem Int Ed Engl; 2020 Aug; 59(33):13865-13870. PubMed ID: 32415712
[TBL] [Abstract][Full Text] [Related]
15. Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
Otyepka M; Bártová I; Kríz Z; Koca J
J Biol Chem; 2006 Mar; 281(11):7271-81. PubMed ID: 16407256
[TBL] [Abstract][Full Text] [Related]
16. Interaction of casein kinase 1 delta (CK1 delta) with the light chain LC2 of microtubule associated protein 1A (MAP1A).
Wolff S; Xiao Z; Wittau M; Süssner N; Stöter M; Knippschild U
Biochim Biophys Acta; 2005 Sep; 1745(2):196-206. PubMed ID: 15961172
[TBL] [Abstract][Full Text] [Related]
17. The kinase domain of CK1δ can be phosphorylated by Chk1.
Böhm T; Meng Z; Haas P; Henne-Bruns D; Rachidi N; Knippschild U; Bischof J
Biosci Biotechnol Biochem; 2019 Sep; 83(9):1663-1675. PubMed ID: 31094292
[TBL] [Abstract][Full Text] [Related]
18. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
Zhang Y; Li H; Hao J; Zhou Y; Liu W
Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
[TBL] [Abstract][Full Text] [Related]
19. Autokinase Activity of Casein Kinase 1 δ/ε Governs the Period of Mammalian Circadian Rhythms.
Guo G; Wang K; Hu SS; Tian T; Liu P; Mori T; Chen P; Johnson CH; Qin X
J Biol Rhythms; 2019 Oct; 34(5):482-496. PubMed ID: 31392916
[TBL] [Abstract][Full Text] [Related]
20. Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.
Alexander A; Karakas C; Chen X; Carey JP; Yi M; Bondy M; Thompson P; Cheung KL; Ellis IO; Gong Y; Krishnamurthy S; Alvarez RH; Ueno NT; Hunt KK; Keyomarsi K
Oncotarget; 2017 Feb; 8(9):14897-14911. PubMed ID: 28107181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
